share_log

If You Invested $1,000 In BioNano (BNGO) Stock At Its COVID-19 Pandemic Low, Here's How Much You'd Have Now

If You Invested $1,000 In BioNano (BNGO) Stock At Its COVID-19 Pandemic Low, Here's How Much You'd Have Now

如果你在新冠肺炎大流行期间投资1,000美元购买生物纳米公司(BioNano)的股票,这是你现在的身价
Benzinga Real-time News ·  2022/09/26 16:16
Investors who bought stocks during the COVID-19 market crash in 2020 have generally experienced some big gains in the past two years. But there is no question some big-name stocks performed better than others since the pandemic bottom.
在2020年新冠肺炎市场崩盘期间买入股票的投资者,在过去两年总体上经历了一些大涨。但毫无疑问,自疫情触底以来,一些大牌股票的表现好于其他股票。
BioNano's Bumpy Road: One company that has been a great investment in the past two years has been biotech stock BioNano Genomics Inc (NASDAQ:BNGO).
生物纳米的坎坷之路:在过去的两年里,有一家公司一直是一笔巨大的投资,那就是生物科技股。生物纳米基因组公司(纳斯达克:bngo)。
BioNano's key technology is its Saphyr System, a cytogenetic testing device that detects structural deficiencies within a cell's nucleus. The system then uses genome mapping for disease diagnosis.
BioNano的关键技术是其Sassir系统,这是一种细胞遗传学测试设备,可以检测细胞核内的结构缺陷。然后,该系统使用基因组图谱进行疾病诊断。
While the FDA has not approved...
虽然FDA还...
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发